Intellectual Property Cases
Cases 71 - 80 of 237
Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al
as 1:2021cv00003
Plaintiff: AMAG Pharmaceuticals, Inc., AMAG Pharma USA, Inc. and Covis Pharma GmbH
Defendant: Aurobindo Pharma, Ltd., Aurobindo Pharma U.S.A., Inc. and Eugia Pharma Specialties Ltd.
Cause Of Action: 35 U.S.C. § 1
MERZ PHARMACEUTICALS, LLC et al v. AUROBINDO PHARMA USA INC. et al
as 3:2020cv20346
Plaintiff: MERZ PHARMACEUTICALS, LLC and MERZ NORTH AMERICA, INC.
Defendant: AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA INC.
Cause Of Action: 35 U.S.C. § 271
Merz Pharmaceuticals, LLC et al v. Aurobindo Pharma Ltd. et al
as 1:2020cv01760
Plaintiff: Merz Pharmaceuticals, LLC and Merz North America, Inc.
Defendant: Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.
Cause Of Action: 35 U.S.C. § 271
PAR PHARMACEUTICAL, INC. et al v. AUROBINDO PHARMA U.S.A., INC. et al
as 3:2020cv18334
Defendant: AUROBINDO PHARMA U.S.A., INC. and AUROBINDO PHARMA LIMITED
Plaintiff: PAR STERILE PRODUCTS, LLC, PAR PHARMACEUTICAL, INC. and ENDO PAR INNOVATION COMPANY, LLC
Cause Of Action: 35 U.S.C. § 271
Astellas Pharma Inc. et al v. Sandoz Inc. et al We have downloadable decisions or orders for this case
as 1:2020cv01589
Defendant: Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff: Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Aurobindo Pharma Ltd. et al
as 1:2020cv01581
Defendant: Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Plaintiff: Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Aurobindo Pharma, Ltd. et al
as 1:2020cv01528
Defendant: Aurobindo Pharma USA, Inc., Aurobindo Pharma, Ltd. and Eugia Pharma Specialties Ltd.
Plaintiff: Pfizer Inc., Warner-Lambert Company LLC and PF PRISM IMB B.V.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Aurobindo Pharma Ltd. et al
as 1:2020cv01426
Defendant: Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Plaintiff: Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. AUROBINDO PHARMA LTD. et al
as 2:2020cv14833
Plaintiff: TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. and NORTON (WATERFORD) LTD.
Defendant: AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA LTD. and AUROLIFE PHARMA LLC
Cause Of Action: 15 U.S.C. § 1126
Merck Sharp & Dohme Corp. v. Aurobindo Pharma, Ltd. et al
as 1:2020cv01099
Defendant: Aurobindo Pharma, Ltd. and Aurobindo Pharma USA Inc.
Plaintiff: Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?